SCHEMBL22658166

SCHEMBL22658166

COc1c(C)cc([N+](=O)[O-])cc1I

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.53
LMNA P02545 2/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
ALDH1A1 P00352 6/20 0.44
TDP1 Q9NUW8 5/20 0.44
TSHR P16473 4/20 0.44
GPR35 Q9HC97 1/20 0.43
CYP3A4 P08684 3/20 0.42
PTGS2 P35354 1/20 0.40
XDH P47989 1/20 0.39
CYP19A1 P11511 1/20 0.38
ERN1 O75460 1/20 0.37
MAPT P10636 3/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL654449 0.87 TSHR (0.52) HTTLMNAMEN1KMT2AALDH1A1
SCHEMBL897060 0.81 HTT (0.52) HTTLMNAMEN1KMT2AALDH1A1
SCHEMBL18725495 0.80 HTT (0.47) HTTLMNAMEN1KMT2AALDH1A1
SCHEMBL5491264 0.80 ALDH1A1 (0.58) HTTLMNAMEN1KMT2AALDH1A1
SCHEMBL12776963 0.80 HTT (0.51) HTTMEN1KMT2AALDH1A1TDP1
SCHEMBL23499773 0.79 ALDH1A1 (0.51) HTTLMNAMEN1KMT2AALDH1A1
SCHEMBL2100704 0.79 ALDH1A1 (0.52) HTTLMNAMEN1KMT2AALDH1A1
SCHEMBL28413881 0.79 TDP1 (0.55) HTTLMNAMEN1KMT2AALDH1A1
SCHEMBL1530547 0.78 HTT (0.53) HTTLMNAMEN1KMT2AALDH1A1
SCHEMBL2434367 0.77 HTT (0.61) HTTLMNAMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3969439-A1 ACSS2 INHIBITORS AND METHODS OF USE THEREOF Metabomed Ltd (IL) 2022-03-23 EP disclosed
WO-2020230134-A1 ACSS2 INHIBITORS AND METHODS OF USE THEREOF METABOMED LTD (IL) 2020-11-19 WO disclosed